Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Curative resection for hilar cholangiocarcinoma: Does adjuvant therapy impact overall survival? A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium. Krasnick, B., Jin, L., Davidson, J., Ethun, C., Pawlik, T. M., Poultsides, G. A., Tran, T., Idrees, K., Isom, C. A., Weber, S. M., Salem, A. I., Hawkins, W. G., Strasberg, S. M., Martin, R. G., Scoggins, C., Shen, P., Mogal, H., Schmidt, C., Maithel, S., Fields, R. C., Tumors, E. AMER SOC CLINICAL ONCOLOGY. 2016
View details for DOI 10.1200/jco.2016.34.4_suppl.388
View details for Web of Science ID 000378109600374